About BeatO
BeatO is a company based in Delhi (India) founded in 2015 by Kunal Kinalekar, Gautam Chopra, and Yash Sehgal. It operates as a HealthTech and Subscription Services. BeatO has raised $50.83 million across 12 funding rounds from investors including Flipkart, PharmEasy and Kotak Mahindra Bank. The company has 142 employees as of April 02, 2024. BeatO has completed 1 acquisition, including Novique Health. BeatO offers products and services including Smart Glucometer and Diabetes Care Program. BeatO operates in a competitive market with competitors including Smit.fit, Diabeto, 7Sugar, JoyHealth and Inayo, among others.
- Headquarter Delhi, India
- Employees 142 as on 02 Apr, 2024
- Founders Kunal Kinalekar, Gautam Chopra, Yash Sehgal
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Health Arx Technologies Pvt. Ltd.
- Date of Incorporation 12 Aug, 2015
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$2.74 M (USD)8.61as on Mar 31, 2023
-
Net Profit
-$6.77 M (USD)-21.11as on Mar 31, 2023
-
EBITDA
-$7.35 M (USD)-28.04as on Mar 31, 2023
-
Total Equity Funding
$50.83 M (USD)
in 12 rounds
-
Latest Funding Round
$170.71 K (USD), Series B
Apr 24, 2023
-
Investors
Flipkart
& 51 more
-
Employee Count
142
as on Apr 02, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BeatO
BeatO offers a comprehensive portfolio of products and services, including Smart Glucometer and Diabetes Care Program.
A USB-connected device for tracking blood sugar levels.
A comprehensive program for managing diabetes effectively online.
People of BeatO
Unlock access to complete
Unlock access to complete
Funding Insights of BeatO
BeatO has successfully raised a total of $50.83M across 12 strategic funding rounds. The most recent funding activity was a Series B round of $170.71 thousand completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Series B — $170,705
-
First Round
First Round
(28 Dec 2015)
- Investors Count 52
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Series B - BeatO | Valuation |
investors |
|
| Feb, 2023 | Amount | Series B - BeatO | Valuation | Republic |
|
| Aug, 2022 | Amount | Series B - BeatO | Valuation | Lightrock India |
Investors in BeatO
BeatO has secured backing from 52 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Flipkart, PharmEasy and Kotak Mahindra Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on early stage companies
|
Founded Year | Domain | Location | |
|
Investments in healthcare companies across India and the US, focusing on building startups in sectors like mental health and diabetes management.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on early-stage investments
|
Founded Year | Domain | Location |
Investments & Acquisitions by BeatO
BeatO has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Novique Health.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Online teleconsultation for diabetes management is provided.
|
2018 |
Financial Statements - BeatO
Beato Comparisons
Competitors of BeatO
BeatO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Smit.fit, Diabeto, 7Sugar, JoyHealth and Inayo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diet and fitness training and monitoring app
|
|
| domain | founded_year | HQ Location |
Diabetes monitoring and management app along with healthcare coaches
|
|
| domain | founded_year | HQ Location |
Online teleconsultation platform for diabetes management is provided.
|
|
| domain | founded_year | HQ Location |
JoyHealth is focused on diabetes management for South Asians.
|
|
| domain | founded_year | HQ Location |
A mobile application designed for monitoring and managing diabetes effectively.
|
Frequently Asked Questions about BeatO
BeatO was founded in 2015.
BeatO is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Gautam Chopra is the current CEO of BeatO. They have also founded this company.
BeatO is a funded company, having raised a total of $50.83M across 12 funding rounds to date. The company's 1st funding round was a Series B of $33M, raised on Dec 28, 2015.
As of Apr 02, 2024, the latest employee count at BeatO is 142.
Annual revenue of BeatO is $2.74M as on Mar 31, 2023.
BeatO is established as Indias foremost platform for diabetes management and treatment. Services are provided through an online home care program, connecting users with clinics, doctors, and science-backed solutions. A smart USB-connected glucometer is offered for monitoring, alongside a comprehensive diabetes care program. Specialized treatment is delivered by leading diabetologists, supported by certified coaches from IIHMR. Focus is placed on achieving lasting sugar reduction and metabolic health through tailored diets and app-based tracking. The platform operates in the digital health sector, emphasizing accessible and affordable healthcare for all.
BeatO offers Smart Glucometer and Diabetes Care Program.
BeatO has made 1 acquisition, including Novique Health.
BeatO has 52 investors. Key investors include Flipkart, PharmEasy, Kotak Mahindra Bank, Republic World, and Parkview Health.
The valuation of BeatO is $93.94M as of Apr 2023.